Acute Lymphoblastic Leukemia: Challenges in MRD Testing
2 Vues
• 08/04/23
0
0
Intégrer
administrator
Les abonnés
Mark R. Litzow, MD; Aaron C. Logan, MD, PhD; Bijal D. Shah, MD; and Ryan D. Cassaday, MD, reflect on challenges presented by minimal residual disease testing in acute lymphoblastic leukemia, such as lack of standardization, risk of oversensitivity, and constantly evolving data in this setting.
Montre plus
Commentaires de Facebook
SORT BY-
Meilleures Commentaires
-
Derniers Commentaires